Trials / Completed
CompletedNCT02138084
Drug-drug Interaction (DDI) Rifabutin
Pharmacokinetic Interaction Study to Evaluate the Pharmacokinetic Effect of Rifabutin on BMS-626529, the Active Moiety of BMS-663068, With and Without Ritonavir in Healthy Subjects
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 102 (actual)
- Sponsor
- ViiV Healthcare · Industry
- Sex
- All
- Age
- 18 Years – 50 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to provide dosing recommendations for the coadministration of BMS-663068 and Rifabutin with and without Ritonavir in upcoming Phase 3 studies and for prescribing information purposes
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | BMS-663068 | BMS-663068 |
| DRUG | Rifabutin | Rifabutin |
| DRUG | Ritonavir | Ritonavir |
Timeline
- Start date
- 2014-05-14
- Primary completion
- 2014-07-24
- Completion
- 2014-07-24
- First posted
- 2014-05-14
- Last updated
- 2017-09-25
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT02138084. Inclusion in this directory is not an endorsement.